The presence of TLS in the CRC macroenvironment fuels anti‐tumour immune responses by increasing the infiltration of CD8+ Tcm, CD8+ Tem, γδ T cells and NKT cells in TME. The gene discussed is CD8A; the disease is colorectal carcinoma.